BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

958 related articles for article (PubMed ID: 18773902)

  • 1. Genomic and epigenetic instability in colorectal cancer pathogenesis.
    Grady WM; Carethers JM
    Gastroenterology; 2008 Oct; 135(4):1079-99. PubMed ID: 18773902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Understanding of Epigenetics Driven Therapeutic Strategies in Colorectal Cancer Management.
    Deka D; Scarpa M; Das A; Pathak S; Banerjee A
    Endocr Metab Immune Disord Drug Targets; 2021; 21(10):1882-1894. PubMed ID: 33605866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic instability and colon cancer.
    Grady WM
    Cancer Metastasis Rev; 2004; 23(1-2):11-27. PubMed ID: 15000146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetics of colon cancer.
    Khare S; Verma M
    Methods Mol Biol; 2012; 863():177-85. PubMed ID: 22359293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation markers in colorectal cancer.
    Kim MS; Lee J; Sidransky D
    Cancer Metastasis Rev; 2010 Mar; 29(1):181-206. PubMed ID: 20135198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis.
    Zoratto F; Rossi L; Verrico M; Papa A; Basso E; Zullo A; Tomao L; Romiti A; Lo Russo G; Tomao S
    Tumour Biol; 2014 Jul; 35(7):6195-206. PubMed ID: 25051912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer: a model for epigenetic tumorigenesis.
    Wong JJ; Hawkins NJ; Ward RL
    Gut; 2007 Jan; 56(1):140-8. PubMed ID: 16840508
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pathological Diagnosis and Its Molecular Basis in Colorectal Cancer].
    Sugai T; Habano W
    Gan To Kagaku Ryoho; 2016 Mar; 43(3):294-9. PubMed ID: 27067845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Intricate Interplay between Epigenetic Events, Alternative Splicing and Noncoding RNA Deregulation in Colorectal Cancer.
    Amirkhah R; Naderi-Meshkin H; Shah JS; Dunne PD; Schmitz U
    Cells; 2019 Aug; 8(8):. PubMed ID: 31430887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated analysis of genetic and epigenetic alterations in cancer.
    Toyota M; Suzuki H; Yamamoto E; Yamano H; Imai K; Shinomura Y
    Epigenomics; 2009 Dec; 1(2):291-9. PubMed ID: 22122704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Migration of mitochondrial DNA in the nuclear genome of colorectal adenocarcinoma.
    Srinivasainagendra V; Sandel MW; Singh B; Sundaresan A; Mooga VP; Bajpai P; Tiwari HK; Singh KK
    Genome Med; 2017 Mar; 9(1):31. PubMed ID: 28356157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial and stromal genetic instability contributes to genesis of colorectal adenomas.
    Ishiguro K; Yoshida T; Yagishita H; Numata Y; Okayasu T
    Gut; 2006 May; 55(5):695-702. PubMed ID: 16354798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The aberrant methylation of TSP1 suppresses TGF-beta1 activation in colorectal cancer.
    Rojas A; Meherem S; Kim YH; Washington MK; Willis JE; Markowitz SD; Grady WM
    Int J Cancer; 2008 Jul; 123(1):14-21. PubMed ID: 18425817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unraveling the Progression of Colon Cancer Pathogenesis Through Epigenetic Alterations and Genetic Pathways.
    Abolghasemi Fard A; Mahmoodzadeh A
    Cureus; 2024 May; 16(5):e59503. PubMed ID: 38826873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CpG island methylator phenotype associates with low-degree chromosomal abnormalities in colorectal cancer.
    Cheng YW; Pincas H; Bacolod MD; Schemmann G; Giardina SF; Huang J; Barral S; Idrees K; Khan SA; Zeng Z; Rosenberg S; Notterman DA; Ott J; Paty P; Barany F
    Clin Cancer Res; 2008 Oct; 14(19):6005-13. PubMed ID: 18829479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic amplification of chromosome 20q13.33 is the early biomarker for the development of sporadic colorectal carcinoma.
    Bui VM; Mettling C; Jou J; Sun HS
    BMC Med Genomics; 2020 Oct; 13(Suppl 10):149. PubMed ID: 33087131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular biology of colorectal cancer.
    Gryfe R; Swallow C; Bapat B; Redston M; Gallinger S; Couture J
    Curr Probl Cancer; 1997; 21(5):233-300. PubMed ID: 9438104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 tumor suppressor gene status and the degree of genomic instability in sporadic colorectal cancers.
    Kahlenberg MS; Stoler DL; Basik M; Petrelli NJ; Rodriguez-Bigas M; Anderson GR
    J Natl Cancer Inst; 1996 Nov; 88(22):1665-70. PubMed ID: 8931611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics/genomics/proteomics of gastric adenocarcinoma.
    Uppal DS; Powell SM
    Gastroenterol Clin North Am; 2013 Jun; 42(2):241-60. PubMed ID: 23639639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer: genetics of development and metastasis.
    Takayama T; Miyanishi K; Hayashi T; Sato Y; Niitsu Y
    J Gastroenterol; 2006 Mar; 41(3):185-92. PubMed ID: 16699851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.